Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
AlphaRx is developing several drug products in the therapeutic categories of Osteoarthritis and Infectious Disease. AlphaRx intends to file IND and NDA submissions with the FDA (when necessary) and license these products to other pharmaceutical companies for worldwide commercialization. The following is a list of AlphaRx’s Pharmaceutical Products in the pipeline: Name Indication Delivery Route Stage Indaflex Ô Osteoarthritis Topical Phase II Rifamsolin Ô Tuberculosis Oral Preclinical Zysolin Ô Pneumonia/Sepsis Parenteral Preclinical Ocusolin Ô Ocular Infection Topical Preclinical Binoxan Ô Ocular Inflammation Topical Preclinical ( www.alpharx.com )
AlphaRx Inc.
75 East Beaver Creek Unit 10
Richmond Hill, Ontario L4B 1B8
Canada
Tel: (905) 762-0745
Fax: (905) 762-0946